Lead Sponsor

Centre Hospitalier Universitaire de Nice

Age

8 - 75 years

Sex

ALL

Healthy Volunteers

No

•Patient with S. aureus or E. coli bacteriostatic bacteremia defined by at least one positive blood culture bottle
•Patient requiring a blood test as part of his bacteremia
•not subject to a judicial protection measure
•Signature of the non-opposition of consent (for minor patients signed by one of the parents or the representative of the parental authority)
•Affiliation to social security

•Immunocompromised patient defined by:
•* current immunosuppressive therapies: corticosteroids, chemotherapy, biotherapy
•* solid organ transplant patient or hematopoietic stem cell transplant
•* chemotherapy-induced neutropenia
•* Congenital immune deficiency
•bacteremia related to a peripheral or central catheter
•Urinary obstruction not lifted within the first 24 hours of management
•Intra-abdominal infection collected undrained in the first 24 hours of management
•primary infectious focus represented by mechanically ventilated pneumonia
•Pregnant or lactating woman

Related studies

NCT06650501 · Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, and more

NCT06749457 · Staphylococcus Aureus

NCT06378359 · Staphylococcus Aureus Colonization, Surgical Site Infections, and more

NCT05632315 · Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, and more

NCT05137119 · Staphylococcus Aureus Bacteremia

Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria